ABIOMED Announces Resignation of John F. Thero.Business Editors DANVERS, Mass.--(BUSINESS WIRE)--Jan. 9, 2003 ABIOMED, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMD ABMD areal bone mineral density ABMD AEGIS Ballistic Missile Defense (US Navy) ABMD Advanced Ballistic Missile Defense ) announced today the resignation of John F. Thero, its Chief Financial Officer, who has decided to pursue a venture-backed opportunity. "John Thero served ABIOMED well for more than eight years as CFO See Chief Financial Officer. and as a member of our senior management team," said ABIOMED's Chief Executive Officer Dr. David M. Lederman. "We thank him for his contributions and wish him well in his new and future endeavors." ABIOMED's Controller, Charles B. Haaser, will serve as Acting Chief Financial Officer until a new CFO is named. Dr. Edward E. Berger, Vice President for Strategic Planning and Policy, will assume interim responsibility for Investor Relations. Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced "AB'-EE-O-MED") is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. The Company's AbioCor(R) Implantable Replacement Heart is part of an ongoing initial clinical trial conducted under an Investigational Device Exemption An Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification [510(k)] submission to Food and from the United States Food and Drug Administration United States Food and Drug Administration (FDA), n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics. . The AbioCor has not been approved for commercial distribution, and is not available for use or sale outside of the initial clinical trial. ABIOMED currently manufactures and sells the BVS BVS Biblioteca Virtual em Saúde (Brazil) BVS Bureau of Vital Statistics BVS Brethren Volunteer Service (Church of the Brethren) BVS Boston Vegetarian Society (Cambridge, MA) (R), a heart assist device for the temporary support of all patients with failing but potentially recoverable hearts. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion